Home › Trial NCT04122430
Risk of Venous Thromboembolism in Patients Receiving First-Line Chemotherapy for Disseminated Germ Cell Tumours
- Trial IDNCT04122430
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorWalter and Eliza Hall Institute of Medical Research
- Enrollment1135
- Start date2015-12
- ConditionsTesticular Neoplasms
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.